Abstract
Case description
A 28-year-old female patient developed an increased temperature and neuropsychiatric symptoms after receiving 75 mg pregabalin therapy for neuralgia. She presented initially with pyrexia and dizziness, followed by disorganized speech within an acute confusional state. Her body temperature returned to normal after taking 60 mg loxoprofen sodium several hours later. However, the neuropsychiatric symptoms did not improve until the next morning. Routine blood tests showed decreased platelet counts (from 131 × 109/L to 85 × 109/L). The following day, a further dose of 75 mg pregabalin was administered because of its effective amelioration of the patient’s neuralgia. One hour later, the same symptoms appeared as had previously including increased body temperature of 39.2 °C accompanied by a lower platelet count (73 × 109/L).
Conclusion
Clinicians should be alert to the serious neuropsychiatric symptoms and thrombocytopenia associated with the use of pregabalin. Routine blood tests may be necessary upon initiation of pregabalin treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Shneker BF, McAulev JM. Pregabalin: a new neuromodulator with broad therapeutic indications. Ann Pharmacother. 2005;39(12):2029–37.
Ogawa S, Satoh J, Arakawa A, Yoshiyama T, Suzuki M. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west. Drug Saf. 2012;35(10):793–806.
Joshi I, Taylor CP. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha 2-delta subunit reduces neurotransmission in mice. Eur J Pharmacol. 2006;553(1–3):82–8.
Guzelkucuk U, Duman I, Yılmaz B, Tan AK. Reversible post-pregabalin peripheral edema in a spinal cord injury patient. Spinal Cord. 2012;50(6):472–3.
Smith TL, Baldwin A, Cunningham LL Jr, Cook AM. Rash associated with pregabalin use. Ann Pharmacother. 2008;42(12):1899–902.
Aksakal E, Bakirci EM, Emet M, Uzkeser M. Complete atrioventricular block due to overdose of pregabalin. Am J Emerg Med. 2012;30(9):2101.e1–4.
Sendra JM, Junyent TT, Pellicer MJ. Pregabalin-induced hepatotoxicity. Ann Pharmacother. 2011;45(6):e32.
Bamanikar A, Dhobale S, Lokwani S. Pregabalin hypersensitivity in a patient treated for postherapeutic neuralgia. Indian J Pharmacol. 2013;45(5):522–3.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.
Okur M, Kaya A, Çaksen H, Taşkın G. Lamotrigine-associated thrombocytopenia and leukopenia. J Emerg Med. 2012;42(5):584–5.
Köse G, Arhan E, Unal B, Ozaydin E, Guven A, Sayli TR. Valproate-associated coagulopathies in children during short-term treatment. J Child Neurol. 2009;24(12):1493–8.
Funding
None.
Conflicts of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Qu, C., Xie, Y., Qin, F. et al. Neuropsychiatric symptoms accompanying thrombocytopenia following pregabalin treatment for neuralgia: a case report. Int J Clin Pharm 36, 1138–1140 (2014). https://doi.org/10.1007/s11096-014-0026-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-014-0026-7